Waterstone Pharmaceuticals(wuhan) Co., Ltd.

The General Hospital Corporation

Waterstone Pharmaceuticals Co., Ltd.

Minglong Hu

Yan Li

Jian Cui

Yao Yu

Faming Zhang

Zhongcong Xie

Tongtong Li

Kang Bie

Ying Liang

Youcheng Zhou

Huiling Tang

Min Fu

The disclosure provides polymers and compositions thereof, as well as methods for preparing such polymers and compositions. Also provided is a method of using the polymers or compositions thereof for binding uric acid or precursor thereof, and/or for treating hyperuricemia, gout, and/or diseases caused by hyperuricemia.

Polymers, compositions and methods for treating hyperuricemia

The present invention relates to a method of treating, preventing, or lessening postoperative cognitive dysfunction (POCD) in a subject in need thereof, the method comprising the step of administering to the subject a therapeutically effective amount of a compound of Formula I or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof,

WS-635 uses thereof in medicine

A crystalline form A of the compound having formula (I) and uses thereof in medicine are described. Specifically, it relates to crystalline form A and pharmaceutically compositions thereof. Furthermore, it relates to the uses of crystalline form A disclosed herein and pharmaceutically compositions thereof disclosed herein in the manufacture of a medicament, especially in the manufacture of a medicament for preventing, managing, treating or lessening hepatitis C vims (HCV) infection.

Crystalline form of compound and uses thereof in medicine

The present invention relates to a salt of a compound of formula (I) and uses thereof in medicine. Specifically, it relates to maleate of compound of formula (I) and pharmaceutically compositions thereof. Furthermore, the invention relates to the uses of maleate herein and pharmaceutically compositions thereof disclosed herein in the manufacture of a medicament, especially in the manufacture of a medicament for preventing, managing, treating or lessening hepatitis C virus (HCV) infection.

Maleate of SCY-635 and uses thereof in medicine

Growing community of inventors

Hubei, China

Minglong Hu